Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035568 · ClinicalTrials.gov registry record · Phase 4
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
A Phase 4 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00035568: Completed Phase 4 study, sponsored by Bristol-Myers Squibb.
NCT00035568 is a Phase 4 study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00035568, a Phase 4 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.
Interventions
- DRUG Glucovance (metformin HCl/glyburide)
- DRUG or Metformin HCl alone
- DRUG or Glyburide alone.
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-02 |
| Est. Completion | 2003-06 |
| Phase | Phase 4 |
What the finished NCT00035568 record still lists
NCT00035568 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Glucovance (metformin HCl/glyburide) is the first listed.
NCT00035568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00035568 about?
NCT00035568 is a clinical study titled "A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes". The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.
What is the current status of trial NCT00035568?
This trial is currently completed. It is a Phase 4 study. The study started on 2002-02. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00035568?
The interventions under investigation include: Glucovance (metformin HCl/glyburide) (DRUG), or Metformin HCl alone (DRUG), or Glyburide alone. (DRUG).
Who is sponsoring clinical trial NCT00035568?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia